AtTEND
18 Nov 2020
AtTEND
ACTRN12619000900112
Phase III Double-Blind Randomized Placebo Controlled Trial of Atezolizumab in Combination with Paclitaxel and Carboplatin in Women with Advanced/Recurrent Endometrial Cancer.
NHMRC/MaNGO
Cancer Type | Gynaecological |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | Female |
Tumour Stream | Enometrial |
Cancer Stage | Locally Recurrent or Locally Advanced; Metastatic or Widespread |
Anticipated Start Date | 2019-10-01 |
Anticipated End Date | 2022-07-31 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Dr Sid Selva |
Recruitment Status | Recruiting |